Talphera Inc

R5XA

Company Profile

  • Business description

    Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.

  • Contact

    1850 Gateway Drive
    Suite 175
    San MateoCA94404
    USA

    T: +1 650 216-3500

    E: [email protected]

    https://www.talphera.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    13

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,773.0029.400.34%
CAC 407,665.9125.64-0.33%
DAX 4023,909.61123.61-0.51%
Dow JONES (US)44,094.77275.500.63%
FTSE 1008,760.9637.95-0.43%
HKSE24,072.28211.87-0.87%
NASDAQ20,369.7396.270.47%
Nikkei 22540,487.39336.600.84%
NZX 50 Index12,609.877.050.06%
S&P 5006,204.9531.880.52%
S&P/ASX 2008,542.3028.100.33%
SSE Composite Index3,444.4320.200.59%

Market Movers